|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02197 CLOVER BIO-B
Nominal 
0.300 -0.005 (-1.639%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | (10,100) | -- | 39,255 | 0 | 0 | 0 |
| Cost of Sales | 1,767 | -- | (15,014) | -- | -- | -- |
| Gross Profit | (8,333) | -- | 24,241 | -- | -- | -- |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (3,807,638) | (597,659) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (95,123) | -- | (138,539) | (2,451,903) | (6,016,303) | (912,898) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (95,123) | -- | (138,539) | (2,451,903) | (6,016,303) | (912,898) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (8,765) | -- | 2,605 | (2,577) | (2,674) | (435) |
| Depreciation & Amortisation | 21,287 | -25.206% | 74,742 | 60,094 | 20,711 | 5,784 |
| Directors' Emoluments | -- | -- | 41,837 | 53,781 | 24,784 | 7,307 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -8.000 | -- | -11.000 | -222.000 | -1,302.000 | -261.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.585) | (1.534) | (1.986) | 1.363 |
| NBV per share ($) | (0.642) | -- | (0.565) | (0.517) | 1.053 | -- |
| Remarks: | Real time quote last updated: 11/11/2024 09:58 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -95,123,000 |
| %Change | -- |
| EPS / (LPS) | RMB -0.080 |
| NBV Per Share (¥) | RMB -0.642 |